Climb Bio, Inc.

NasdaqGM:CLYM 株式レポート

時価総額:US$236.1m

Climb Bio マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Aoife Brennan

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権n/a
経営陣の平均在職期間less than a year
取締役会の平均在任期間4.6yrs

経営陣の近況

Recent updates

Eliem Therapeutics: Recent Strategic Pipeline Restructuring

Sep 23

Eliem Therapeutics: Year End 2024 MN Data With Further Potential To Unlock Value

Jun 28

Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation

Feb 01
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation

We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully

Jun 24
We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully

We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Mar 08
We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Nov 18
We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Eliem Therapeutics GAAP EPS of -$0.56 misses by $0.09

Aug 15

Eliem to discontinue development of lead asset as mid-stage pain trial fails

Aug 02

SVB Leerink cuts PT on Eliem Therapeutics, reaffirms Outperform rating

Jul 11

CEO(最高経営責任者

Aoife Brennan (48 yo)

no data

在職期間

Dr. Aoife M. Brennan, M.D. M.B., Ch B., BAO, MMSc, MRCPI, is CEO, President and Director at Climb Bio, Inc. (formerly known as Eliem Therapeutics, Inc.) Dr. Brennan serves as Director of Xilio Therapeutics...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Aoife Brennan
CEO, President & Directorno dataデータなしデータなし
Brett Kaplan
COO & Principal Financial Officerless than a yearデータなしデータなし
Emily Pimblett
Chief Accounting Officer1.8yrsデータなし0.011%
$ 26.6k
Jo Palmer-Phillips
Chief Development Officerno dataデータなしデータなし
Nishi Rampal
Senior Vice President of Clinical Developmentless than a yearデータなしデータなし

0.3yrs

平均在職期間

48yo

平均年齢

経験豊富な経営陣: CLYMの経営陣は 経験豊富 とはみなされません ( 0.3年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Aoife Brennan
CEO, President & Directorno dataデータなしデータなし
Adam Rosenberg
Independent Director4.1yrsUS$77.16k0.27%
$ 626.9k
Liam Ratcliffe
Lead Independent Director5.1yrsUS$71.33k0%
$ 0
Simon Tate
Independent Director5.8yrsUS$22.52k0%
$ 0
Andrew Levin
Co-Founder & Chairman5.8yrsUS$87.91k0%
$ 0
Stephen Thomas
Directorless than a yearデータなし0.15%
$ 365.8k
Judith Dunn
Independent Director3.8yrsUS$69.66k0%
$ 0

4.6yrs

平均在職期間

54yo

平均年齢

経験豊富なボード: CLYMの 取締役会経験豊富 であると考えられます ( 4.6年の平均在任期間)。